Computational Studies on T2Rs Agonist-Based Anti–COVID-19 Drug Design

The expeditious and world pandemic viral disease of new coronavirus (SARS-CoV-2) has formed a prompt urgency to discover auspicious target-based ligand for the treatment of COVID-19. Symptoms of novel coronavirus disease (COVID-19) typically include dry cough, fever, and shortness of breath. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhanaraj, Premnath, Muthiah, Indiraleka, Rozbu, Mahtabin Rodela, Nuzhat, Samiha, Paulraj, Mosae Selvakumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416165/
https://www.ncbi.nlm.nih.gov/pubmed/34485378
http://dx.doi.org/10.3389/fmolb.2021.637124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416165/
https://www.ncbi.nlm.nih.gov/pubmed/34485378
http://dx.doi.org/10.3389/fmolb.2021.637124

Ejemplares similares